Carprieve Tablets

£35.64 - £298.35 (exc VAT)

£42.77 - £358.02 (inc VAT)

A light brown, round, flat bevel edged tablet and can be divided into equal halves. Carprieve Tablets are available in three strengths with the following active composition:

20 mg Carprofen
50 mg Carprofen
100 mg Carprofen

It's uses include:

  • For Analgesia amd reduction of inflammation i.e. degenerative joint disease in dogs.
  • Management of post-operative pain.

Legal Category: POM-V


Oral administration to dogs. An initial dose of 2 to 4mg carprofen/kg bodyweight/day is recommended to be give in 2 equally divided doses. The dose may be reduced to 2mg carprofen/kg bodyweight/day administered as a single daily dose after 7 days, subject to clinical response.


Do not use in cats. The elimination time of NSAIDs, including carprofen, in the cat is longer than in the dog and the therapeutic index is narrower. In the absence of specific data use in the cat is contra- indicated.

Do not exceed the stated dose.

Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia or hypersensitivity to the product. As with other NSAIDs there is a risk of rare idiosyncratic renal or hepatic adverse effects.

Typical undesirable effects associated with NSAIDs, such as vomiting, soft faeces/diarrhoea, faecal occult blood, loss of appetite and lethargy have been reported. These adverse reactions generally occur within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.

Do not use in puppies less than 4 months.

Use in aged dogs may involve additional risk. If such a use cannot be avoided, such dogs may require a reduced dosage and careful clinical management.

Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential rise of increased renal toxicity.

NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated.

Do not use in case of hypersensitivity to active substance or to any of the excipients. Carprofen is highly bound to plasma proteins and compete with other highly bound drugs, which can increase their respective toxic effects. Do not use this veterinary medicinal product concurrently with or within 24 hours of other NSAIDs or concurrently with glucocorticoids. Concurrent administration of potentially nephrotoxic drugs should be avoided.

Do not administer concurrently with anticoagulants.

The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Do not use in pregnant or lactating bitches. For breeding animals, do not use during reproduction period.

Due to the palatable nature of the tablets, store in a secure location. Severe adverse reactions may occur if large quantities are ingested. If you suspect your dog has consumed Carprieve Flavoured Tablets above the labelled dose, please contact your veterinarian.

In case of accidental ingestion seek medical advice and show the package leaflet or the label to the physician. Wash hands after handling product.

For the most up to date information about this product please look up the Summary of Product Characteristics (SPC) on the VMD webpage Product Information Database.




20mg x 100 tablets Price: £35.64 (exc VAT)

POM-V Declaration

50mg x 100 tablets Price: £85.66 (exc VAT)

POM-V Declaration

100mg x 100 tablets Price: £124.05 (exc VAT)

POM-V Declaration

50mg x 500 tablets Price: £298.35 (exc VAT)

POM-V Declaration